Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Scheurer, Michael E ^a   Dillon, Laura M ^b   Chen, Zhuo ^c   Follen, Michele ^b   Adler Storthz, Karen ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247882715     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-8     Document Type: Article

References (39)

1. Syrjanen K, Syrjanen S: Epidemiology of genital HPV infections. In Papillomavirus Infections in Human Pathology Edited by: Syrjanen K. and Syrjanen S. New York, John Wiley; 2000:117-142.
2. Ostor AG: Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993, 12:186-192.
3. Hawley-Nelson P, Vousden KH, Hubbert ML, Lowy DR, Schiller JT: HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 1989, 8:3905-3910.
4. Song S, Liem A, Miller JA, Lambert PF: Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 2000, 267:141-150.
5. Nindl l, Rindfleisch K, Lotz B, Schneider A, Durst M: Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 1999, 82:203-207.
6. Zehbe I, Wilander E, Delius H, Tommasino M: Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998, 58:829-833.
7. Flores ER, Allen-Hoffmann BL, Lee D, Lambert PF: The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. j Viral 2000, 74:6622-6631.
8. Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB: Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papillomavirus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther 1995, 2:19-32.
9. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM: Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989, 8:4099-4105.
10. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K:The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 2000, 97:10002-10007.
11. Duensing S, Duensing A, Crum CP, Munger K: Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res 2001, 61:23 56-2360.
12. Brehm A, Kouzarides T: Retinoblastoma protein meets chromatin. Trends Biochem Sci 1999, 24:142-145.
13. Steenbergen RD, Hermsen MA, Walboomers JM, Meijer GA, Baak JP, Meijer CJ, Snijders PJ: Non-random allelic losses at 3p, 11p and 13q during HPV-mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes. Int J Cancer 1998, 76:412-417.
14. Durst M, Glitz D, Schneider A, zur HH: Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 1992, 189:132-140.
15. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR: Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992, 23:117-128.
16. Kraus I, Molden T, Erno LE, Skomedal H, Karlsen F, Hagmar B: Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones. Sr J Cancer 2004, 90:1407-1413.
17. Nakagawa S, Yoshikawa H, Yasugi T, Kimura M, Kawana K, Matsumoto K, Yamada M, Onda T, Taketani Y: Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type. J Med Virol 2000, 62:251-258.
18. Sotlar K, Selinka HC, Menton M, Kandolf R, Bultmann B: Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR. Gynecol Oncol 1998, 69:114-121.
19. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL: Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 2002, 94:2199-2210.
20. Kozuka T, Aoki Y, Nakagawa K, Ohtomo K, Yoshikawa H, Matsumoto K, Yoshiike K, Kanda T: Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies. Jpn J Cancer Res 2000, 91:271 -279.
21. Rajeevan MS, Swan DC, Nisenbaum R, Lee DR, Vernon SD, Ruffin MT, Horowitz IR, Flowers LC, Kmak D, Tadros T, Birdsong G, Husain M, Srivastava S, Unger ER: Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer 2005, 115:114-120.
22. Rosner B: Fundamentals of biostatistics Pacific Grove, CA, Duxbury; 2000.
23. Bosch FX, Munoz N, de Sanjose S, Navarro C, Moreo P, Ascunce N, Gonzalez LC, Tafur L, Gili M, Larranaga I: Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993, 2:415-422.
24. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB: Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000, 355:2189-2193.
25. Morrison EA, Ho GY, Vermund SH, Goldberg G L, Kadish AS, Kelley KF, Burk RD: Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 1991, 49:6-13.
26. Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP: Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type., J Clin Microbiol 1999, 37:1030-1034.
27. Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, Adami HO, Gyllensten UB, Melbye M: Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000, 355:2194-2198.
28. Flores R, Papenfuss M, Klimecki WT, Giuliano AR: Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 2006, 118:1187-1193.
29. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M: Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002, 360:228-229.
30. Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL: Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003, 103:519-524.
31. Fahey MT, Irwig L, Macaskill P: Meta-analysis of Pap test accuracy. Am J Epidemiol 1995, 141:680-689.
32. Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg MD, Morales J, Rodriguez AC, Schussler J, Eklund C, Marshall G, Schiffman M: A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 2003, 12:815-823.
33. Hsu EM, McNicol PJ: Characterization of HPV-16 E6/E7 transcription in CaSki cells by quantitative PCR. Mol Cell Probes 1992, 6:459-466.
34. Falcinelli C, van Belkum A, Schrauwen L, Seldenrijk K, Quint WG: Absence of human papillomavirus type 16 E6 transcripts in HPV 16-infected, cytologically normal cervical scrapings. J Med Virol 1993, 40:261-265.
35. Cuschieri KS, Beattie G, Hassan S, Robertson K, Cubie H: Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology medium, J Virol/Methods 2005, 124:211-215.
36. Scheurer ME, Tortolero-Luna G, Guillaud M, Folien M, Chen Z, Dillon LM, Adler-Storthz K: Correlation of human papillomavirus type 16 and human papillomavirus type 18 e7 messenger RNA levels with degree of cervical dysplasia. Cancer Epidemiol Biomarkers Prey 2005, 14:1948-1952.
37. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, Manos MM : Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990, 82(18):1477-84.
38. Ke LD, Adler-Storthz K, Mitchell MF, Clayman GL, Chen Z: Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. Oral Oncol 1999, 35:415-420.
39. Narechania A, Chen Z, DeSalle R, Burk RD: Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol 2005, 79:15503-15510.